News : 2014 : August

Rong Wen, M.D., Ph.D.

Bascom Palmer Licenses Retinal Disorder Product to Biotech Company

In a deal that may lead to the first viable treatment for retinal diseases, Amarantus Bioscience Holdings, Inc., a biotechnology company, has exercised its exclusive right to license intellectual property related to a protein product developed by a researcher at the Miller School of Medicine’s Bascom Palmer Eye Institute.

Read more »